Eone-Diagnomics Genome Center Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
72
- Stock Symbol
-
245620
- Investments
-
3
- Share Price
-
$0.31
- (As of Friday Closing)
Eone-Diagnomics Genome Center General Information
Description
Eone Diagnomics Genome Center Co Ltd is engaged in developing and personalizing medicine based on Next Generation Sequencing technology and cutting-edge genomics analysis. The company provides various personal genome sequencing and bioinformatics solutions to biomedical researchers, physicians and individuals seeking to understand the genetic influence of personal health and disease.
Contact Information
Website
www.edgc.comCorporate Office
- 291, Harmony-ro
- Yeonsu-gu
- Incheon, 22014
- South Korea
Corporate Office
- 291, Harmony-ro
- Yeonsu-gu
- Incheon, 22014
- South Korea
Eone-Diagnomics Genome Center Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.31 | $0.33 | $0.26 - $1.40 | $42.5M | 138M | 8.04M | -$0.30 |
Eone-Diagnomics Genome Center Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 79,304 | 94,183 | 183,828 | 270,004 |
| Revenue | 40,455 | 67,656 | 72,937 | 77,947 |
| EBITDA | (4,803) | (14,626) | (10,523) | (6,092) |
| Net Income | (18,268) | (25,260) | (23,113) | (18,043) |
| Total Assets | 108,813 | 134,649 | 152,038 | 157,088 |
| Total Debt | 44,321 | 55,124 | 66,285 | 47,496 |
Eone-Diagnomics Genome Center Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Eone-Diagnomics Genome Center Comparisons
Industry
Financing
Details
Eone-Diagnomics Genome Center Competitors (4)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Guardant Health | Formerly VC-backed | Palo Alto, CA | ||||
| GRAIL | Formerly VC-backed | Menlo Park, CA | ||||
| 23andMe | Formerly VC-backed | San Francisco, CA |
Eone-Diagnomics Genome Center Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Eone-Diagnomics Genome Center Patents
Eone-Diagnomics Genome Center Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4108784-A1 | Marker selection method using methylation difference between nucleic acids, methylated or demethylated marker, and diagnostic method using marker | Pending | 20-Feb-2020 | ||
| US-20230064274-A1 | Marker selection method using methylation difference between nucleic acids, methylated or demethylated marker, and diagnostic method using marker | Pending | 20-Feb-2020 | ||
| US-20230059086-A1 | Double-stranded nucleic acid molecules and method for removing glass adaptor in dna library by means of same | Pending | 26-Dec-2019 | ||
| EP-4083205-A1 | Double-stranded nucleic acid molecules and method for removing glass adaptor in dna library by means of same | Pending | 26-Dec-2019 | ||
| EP-4083205-A4 | Double-stranded nucleic acid molecules and method for removing glass adaptor in dna library by means of same | Pending | 26-Dec-2019 | C12N15/1093 |
Eone-Diagnomics Genome Center Executive Team (10)
| Name | Title | Board Seat |
|---|---|---|
| Seongmin Jo | Co-Chief Executive Officer & President | |
| Shin Cheol | Chief Executive Officer | |
| MinSeob Lee Ph.D | Co-Chief Executive Officer | |
| Seongha Lee | Chief Operating Officer & President | |
| SungHoon Lee Ph.D | Chief Technology Officer & Vice President |
Eone-Diagnomics Genome Center Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Eone-Diagnomics Genome Center Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Eone-Diagnomics Genome Center Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| GDXLAB | 25-Oct-2023 | Laboratory Services (Healthcare) | |||
| Natural Life Nutrition | 28-Jul-2021 | Other Commercial Services | |||
| SolGent | 12-Oct-2014 | Later Stage VC | Biotechnology |
Eone-Diagnomics Genome Center Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Natural Life Nutrition | Other Commercial Services | Burnaby, Canada | 2000 |
| GDXLAB | Laboratory Services (Healthcare) | Englewood, CO |
Eone-Diagnomics Genome Center ESG
Risk Overview
Risk Rating
Updated April, 01, 2022
31.69 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,860
Rank
Percentile
Commercial Services
Industry
of 453
Rank
Percentile
Business Support Services
Subindustry
of 184
Rank
Percentile
Eone-Diagnomics Genome Center Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| SolGent | 12-Oct-2014 | Completed |
|
Eone-Diagnomics Genome Center FAQs
-
When was Eone-Diagnomics Genome Center founded?
Eone-Diagnomics Genome Center was founded in 2013.
-
Who is the CEO of Eone-Diagnomics Genome Center?
Seongmin Jo, Shin Cheol, MinSeob Lee Ph.D, and Min Lee Ph.D are the CEOs of Eone-Diagnomics Genome Center.
-
Where is Eone-Diagnomics Genome Center headquartered?
Eone-Diagnomics Genome Center is headquartered in Incheon, South Korea.
-
What is the size of Eone-Diagnomics Genome Center?
Eone-Diagnomics Genome Center has 72 total employees.
-
What industry is Eone-Diagnomics Genome Center in?
Eone-Diagnomics Genome Center’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Eone-Diagnomics Genome Center a private or public company?
Eone-Diagnomics Genome Center is a Public company.
-
What is Eone-Diagnomics Genome Center’s stock symbol?
The ticker symbol for Eone-Diagnomics Genome Center is 245620.
-
What is the current stock price of Eone-Diagnomics Genome Center?
As of 05-Apr-2024 the stock price of Eone-Diagnomics Genome Center is $0.31.
-
What is the current market cap of Eone-Diagnomics Genome Center?
The current market capitalization of Eone-Diagnomics Genome Center is $42.5M.
-
What is Eone-Diagnomics Genome Center’s current revenue?
The trailing twelve month revenue for Eone-Diagnomics Genome Center is $40.5M.
-
Who are Eone-Diagnomics Genome Center’s competitors?
Illumina, Guardant Health, GRAIL, and 23andMe are competitors of Eone-Diagnomics Genome Center.
-
What is Eone-Diagnomics Genome Center’s annual earnings per share (EPS)?
Eone-Diagnomics Genome Center’s EPS for 12 months was -$0.30.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
